Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 1/2019

25.01.2018 | Original Article

Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures

verfasst von: Melissa F. P. Santos, Mariel J. Hernández, Ivone B. de Oliveira, Flávia R. Siqueira, Wagner V. Dominguez, Luciene M. dos Reis, Aluizio B. Carvalho, Rosa M. A. Moysés, Vanda Jorgetti

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Chronic kidney disease-mineral bone disorders (CKD-MBD) are associated with increased risk of fracture. Studies report about 3% of fractures in CKD patients, and these occur earlier than in the general population, namely 16 and 13 years earlier for men and women, respectively. Better understanding of the pathophysiology of fractures would probably contribute to new therapeutic approaches. This study aimed to evaluate report of long bone fractures from a bone biopsies bank from patients on hemodialysis and compare clinical and biochemical characteristics, as well as the results of the histomorphometric analysis of trabecular and cortical bone of these patients with a control group (without fractures), paired for age, gender, and time on hemodialysis. Bone proteins (SOST, DMP1 and MEPE) were evaluated by immunohistochemistry. Seventeen patients with fracture and controls were studied. Fracture prevalence was 0.82/1000 patients/year. Serum phosphorus levels were significantly lower in the fracture group. Histomorphometric analysis revealed that all the patients had high turnover disease, and the fracture group had smaller volume and trabecular thickness, greater osteoid surface, smaller eroded surface, smaller mineralizing surface, formation rate and longer mineralization lag time when compared to controls; the DMP1 expression in the cortical bone was smaller and the SOST in the trabecular bone was higher in fractured patients. As conclusion, we found low prevalence of fractures. Both groups had high turnover disease, but the fractured ones presented more impaired bone microarchitecture, as well as lower formation and greater mineralization defect. Bone proteins expression correlated with parameters involved in bone remodeling.
Literatur
2.
Zurück zum Zitat Jamal SA (2010) Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hypertens 19:343–348CrossRefPubMed Jamal SA (2010) Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hypertens 19:343–348CrossRefPubMed
3.
Zurück zum Zitat Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289CrossRefPubMed Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289CrossRefPubMed
4.
Zurück zum Zitat Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed
5.
Zurück zum Zitat Coco M, Rush H (2000) Increased incidence of hip fracture in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115–1121CrossRefPubMed Coco M, Rush H (2000) Increased incidence of hip fracture in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115–1121CrossRefPubMed
6.
Zurück zum Zitat De Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87:1039–1045CrossRefPubMed De Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87:1039–1045CrossRefPubMed
7.
Zurück zum Zitat Gomes SA, dos Reis LM, de Oliveira IB, Noronha IL, Jorgetti V, Heilberg IP (2008) Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate: an improved method for immunohistochemistry. J Bone Miner Metab 26:110–113CrossRefPubMed Gomes SA, dos Reis LM, de Oliveira IB, Noronha IL, Jorgetti V, Heilberg IP (2008) Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate: an improved method for immunohistochemistry. J Bone Miner Metab 26:110–113CrossRefPubMed
8.
Zurück zum Zitat Graciolli FG, Neves KR, Barreto F, Barreto DV, dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moyses RMA (2017) The complexity of chronic disease-mineral and bone across stages of chronic kidney disease. Kidney Int 91:1436–1446CrossRefPubMed Graciolli FG, Neves KR, Barreto F, Barreto DV, dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moyses RMA (2017) The complexity of chronic disease-mineral and bone across stages of chronic kidney disease. Kidney Int 91:1436–1446CrossRefPubMed
9.
Zurück zum Zitat Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for Bone Histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17CrossRefPubMed Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for Bone Histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17CrossRefPubMed
10.
Zurück zum Zitat Dos Reis LM, Batalha JR, Muñoz DR, Borelli A, Correa PH, Carvalho AB, Jorgetti V (2007) Brazilian normal static bone histomorphometry: effects of age, sex and race. J Bone Miner Metab 25:400–406CrossRefPubMed Dos Reis LM, Batalha JR, Muñoz DR, Borelli A, Correa PH, Carvalho AB, Jorgetti V (2007) Brazilian normal static bone histomorphometry: effects of age, sex and race. J Bone Miner Metab 25:400–406CrossRefPubMed
11.
Zurück zum Zitat Rehman MTA, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47:529–534CrossRefPubMedPubMedCentral Rehman MTA, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47:529–534CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953CrossRefPubMed Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953CrossRefPubMed
13.
Zurück zum Zitat Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166–173CrossRefPubMed Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166–173CrossRefPubMed
14.
Zurück zum Zitat Miller PD (2016) Underdiagnoses and undertreatment of osteoporosis: the battle to be won. J Clin Endocrinol Metab 101:852–859CrossRefPubMed Miller PD (2016) Underdiagnoses and undertreatment of osteoporosis: the battle to be won. J Clin Endocrinol Metab 101:852–859CrossRefPubMed
15.
Zurück zum Zitat Goldenstein PT, Elias RM, Pires de Freitas do Carmo L, Coelho FO, Magalhães LP, Antunes GL, Custódio MR, Montenegro FL, Titan SM, Jorgetti V, Moysés RM (2013) Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study. PLoS One 8:e68870CrossRefPubMedPubMedCentral Goldenstein PT, Elias RM, Pires de Freitas do Carmo L, Coelho FO, Magalhães LP, Antunes GL, Custódio MR, Montenegro FL, Titan SM, Jorgetti V, Moysés RM (2013) Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study. PLoS One 8:e68870CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1–59CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1–59CrossRef
18.
Zurück zum Zitat Chappard D, Bizot D, Mabilleau G, Hubert L (2016) Aluminum and bone: review of new circumstances associated with Al3+ deposition in the calcified matrix of bone. Morphologie 100:95–105CrossRefPubMed Chappard D, Bizot D, Mabilleau G, Hubert L (2016) Aluminum and bone: review of new circumstances associated with Al3+ deposition in the calcified matrix of bone. Morphologie 100:95–105CrossRefPubMed
19.
Zurück zum Zitat Zheng CM, Zheng JQ, Wu CC, Lu CL, Shyu JF, Yung-Ho H, Wu MY, Chiu IJ, Wang YH, Lin YF, Lu KC (2016) Bone loss in chronic kidney disease: quantity or Quality? Bone 6:57–70CrossRef Zheng CM, Zheng JQ, Wu CC, Lu CL, Shyu JF, Yung-Ho H, Wu MY, Chiu IJ, Wang YH, Lin YF, Lu KC (2016) Bone loss in chronic kidney disease: quantity or Quality? Bone 6:57–70CrossRef
21.
Zurück zum Zitat Barger-Lux MJ, Recker RR (2002) Bone microstructure in osteoporosis: transilial biopsy and histomorphometry. Top Magn Reson Imaging 13:297–306CrossRefPubMed Barger-Lux MJ, Recker RR (2002) Bone microstructure in osteoporosis: transilial biopsy and histomorphometry. Top Magn Reson Imaging 13:297–306CrossRefPubMed
22.
Zurück zum Zitat Hanudel MR, Froch L, Gales B, Jüppner H, Salusky IB (2017) Fractures and osteomalacia in a patient treated with frequent home hemodialysis. Am J Kidney Dis 70:445–448CrossRefPubMedPubMedCentral Hanudel MR, Froch L, Gales B, Jüppner H, Salusky IB (2017) Fractures and osteomalacia in a patient treated with frequent home hemodialysis. Am J Kidney Dis 70:445–448CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K (2009) Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 45:1161–1168CrossRefPubMedPubMedCentral Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K (2009) Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 45:1161–1168CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Suzuki S, Haruyama N, Nishimura F, Kulkarni AB (2012) Dentin sialophosphoprotein and dentin matrix protein-1: two highly phosphorylated proteins in mineralized tissues. Arch Oral Biol 57:1165–1175CrossRefPubMedPubMedCentral Suzuki S, Haruyama N, Nishimura F, Kulkarni AB (2012) Dentin sialophosphoprotein and dentin matrix protein-1: two highly phosphorylated proteins in mineralized tissues. Arch Oral Biol 57:1165–1175CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Winkler DG, Sutherland MK, Georghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22:6267–6276CrossRefPubMedPubMedCentral Winkler DG, Sutherland MK, Georghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22:6267–6276CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25:695–705CrossRefPubMed Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25:695–705CrossRefPubMed
Metadaten
Titel
Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures
verfasst von
Melissa F. P. Santos
Mariel J. Hernández
Ivone B. de Oliveira
Flávia R. Siqueira
Wagner V. Dominguez
Luciene M. dos Reis
Aluizio B. Carvalho
Rosa M. A. Moysés
Vanda Jorgetti
Publikationsdatum
25.01.2018
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 1/2019
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-018-0902-7

Weitere Artikel der Ausgabe 1/2019

Journal of Bone and Mineral Metabolism 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.